Healthcare spending growth flat in 2017, but two emerging trends may change that
The pharmaceutical segment, which still accounts for a significant portion of our spending, has mostly recovered from the huge spike from expensive specialty drugs to
Home » Industry News » Page 7
The pharmaceutical segment, which still accounts for a significant portion of our spending, has mostly recovered from the huge spike from expensive specialty drugs to
If you look at some of the statistics out there about Meaningful Use in Electronic Health Records (EHRs), approximately 90 percent of practices are actually
It is assumed by many that our rapid adoption of high technology and high spending on health care must bring us the best health care.
Were it not for the skyrocketing cost of specialty pharmaceuticals, next year’s rate of increase in health care costs for large companies could be among
Amgen announced that the U.S. Food and Drug Administration (FDA) has approved the Repatha (evolocumab) Pushtronex™ system (on-body infusor with prefilled cartridge), a new, monthly single-dose administration option.1 The
Last month, the Food and Drug Administration (FDA) approved another in a series of medicines that have dramatically changed the outlook for those diagnosed with
A new set of voluntary state guidelines encourages physicians to be judicious when prescribing painkillers, Gov. Tom Wolf and top state health officials said Tuesday.
It’s no secret that prescription drug prices are the fastest rising part of our health care system. That’s especially true in the cases of specialty
Lowcost Pharmacy Benefit Management
877.877.5711
info@arayarx.com
PO Box 460
Latham, NY 12110